Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low-Dose Tamoxifen for Radiation-Induced Breast Cancer Risk Reduction: A Phase IIB Randomized Placebo-Controlled Trial

NCT01196936 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.

NCT NCT01196936
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01196936 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low-Dose Tamoxifen for Radiation-Induced Breast Cancer Risk Reduction: A Phase IIB Randomized Placebo-Controlled Trial
Lead sponsor
University of Alabama at Birmingham
Phase
Phase 2
Overall status
Active, not recruiting
Start date
September 30, 2010
Completion date
December 11, 2028
Enrollment
84 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer